Stay updated on ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial.
Sign up to get notified when there's something new on the ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial. page.

Latest updates to the ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial. page
- Check8 days agoChange DetectedPage shows a new revision tag (Revision: v3.3.4) replacing the previous tag (Revision: v3.3.3). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedLocation sections were updated to reflect added study sites in California, Florida, Pennsylvania, Texas, New South Wales, Queensland, Victoria, and Western Australia, with older site lists removed. The page revision is updated to v3.3.3 (replacing v3.3.2).SummaryDifference1.0%

- Check57 days agoChange DetectedThe Publications section now notes that items are auto-filled from PubMed and may not pertain to the study, and the revision label in the page footer changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check64 days agoChange DetectedThe government funding/operating-status notice was removed. The study details, eligibility criteria, and enrollment information remain unchanged.SummaryDifference0.4%

- Check86 days agoChange DetectedNo additions or deletions were detected; the page's core content and study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check107 days agoChange Detected- Updated version from v3.1.0 to v3.2.0. - Added a government-operating-status notice about funding lapse and the NIH Clinical Center openness, directing users to cc.nih.gov and opm.gov for status updates.SummaryDifference3%

Stay in the know with updates to ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial.
Enter your email address, and we'll notify you when there's something new on the ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial. page.